升温速率对冷轧超薄取向硅钢再结晶行为的影响

利用EBSD技术对比分析了升温速率对冷轧超薄取向硅钢再结晶行为的影响.结果表明,冷轧超薄带中再结晶形核位置、再结晶织构类型受升温速率的影响不大,主要取决于形变组织;剪切带、{111}〈112〉取向晶粒晶界、形变带和形变不均匀区均为再结晶的形核位置,剪切带的再结晶形核优势更为明显;再结晶晶粒取向以Goss({110}〈001〉)取向为主,同时存在{210}〈001〉、{310}〈001〉以及一定比例的杂乱取向.然而,升温速率显著影响Goss织构的强度及退火样品的组织均匀性;慢速升温条件下,Goss织构比例和锋锐度降低,说明回复导致不同织构的形变组织储存能差异减小,降低了Goss取向的形核优势;快速升温条件下,剪切带内的Goss晶核具有更大的形核优势,吞并临近的形变组织完成再结晶,形成更强和锋锐的Goss织构.此外,快速升温可提高再结晶完成后的组织均匀性、降低平均晶粒尺寸.     

预处理工艺对双辊铸轧3003铝合金再结晶行为的影响

对双辊铸轧3003铝合金板材进行了3种预处理退火,研究不同预处理工艺下的冷轧板材在380～500℃退火时晶粒组织和再结晶织构的变化规律。结果表明:最优化预处理工艺为610℃/12h+460℃/12h,高温阶段第二相尺寸发生粗化,低温阶段基体中Mn的过饱和固溶度显著降低,两者均有利于提高后续退火时的再结晶形核率。500℃退火时,在粗大第二相的附近产生了粒子诱发形核机制,降低了再结晶织构强度;并且退火时几乎不存在析出,析出相对再结晶形核的抑制作用甚微,从而得到了晶粒细小、织构弱的再结晶组织。     

中间退火及成品退火速率对高压阳极铝箔微观组织的影响

采用不同中间退火温度及成品退火速率对高压阳极铝箔进行处理,并利用EBSD及XRD技术分析其微观组织结构,尤其是织构的变化规律。结果表明,中间退火温度对后续成品退火中形成立方织构起到了关键作用,这可能是由于低温中间退火保留了大量的形变储能,为成品退火时立方织构的形成增加了形核核心。同时,低的中间退火温度造成立方织构较理想位置偏转程度更大。随着成品退火加热速率的增大,铝箔再结晶分数及再结晶晶粒尺寸逐渐减小,这是由于退火加热速率的增大(低于临界加热速率),缩短了晶界迁移的时间,减缓了再结晶的发生。     

深冲IF钢再结晶{111}纤维织构形成机制探讨

为了探讨深冲IF钢再结晶织构与退火温度之间的关系及{111}再结晶织构形成机制,采用X射线衍射三维取向(ODF)和背散射电子衍射(EBSD)分析技术并结合金相组织观察,利用Gibbs-Thom son方程对冷轧IF钢在不同退火温度下的再结晶织构演变规律及形成机制进行研究.实验结果表明:随着退火温度的增加,再结晶量逐渐增多,γ纤维织构强度亦相应增强,同时,α纤维织构强度则逐渐降低;冷轧IF钢再结晶初期的织构转变主要发生在γ纤维织构之间.研究表明,再结晶核心的形成主要以"显微择优形核"为主,晶核的长大则主要以择优生长为主,而Σ重位点阵晶界在再结晶γ纤维织构形成过程中起着重要作用.     

常化退火处理对无取向硅钢组织和织构的影响

采用光学显微镜和X射线衍射仪研究了常化退火处理对无取向硅钢热轧板和成品退火板显微组织和织构的影响。结果表明:常化退火处理消除了热轧板中的变形组织,促使变形晶粒完成再结晶;常化退火处理使高斯织构和立方织构易通过再结晶在变形带内形核和长大,可显著降低成品退火板的{111}和{112}不利织构组分的占有率,提高{100}和{110}有利织构组分的占有率,从而有利于提高无取向硅钢成品板的磁性能。     

电场对Al-Mn-Mg合金的微结构和织构形成的影响

利用透射电子显微镜观察(TEM)和X射线衍射技术(ODFs分析),研究了电场对Al-Mn-Mg合金的回复和再结晶组织演变、再结晶织构的形成和发展的影响.结果表明,电场对再结晶的影响其强度有一个门槛值(3～4 kV/cm),低于此值电场对该合金的再结晶没有明显的影响.强度为4 kV/cm的电场对再结晶形核的影响较大,可抑制Al-Mn-Mg合金的回复和再结晶,促进再结晶立方织构的形成.其主要原因是电场降低了各取向的形变储能,推迟了再结晶进程,抑制储存能小的取向晶核的形成和长大,促进储存能大的S取向晶粒向立方织构择优生长.     

微碳DP钢在连续退火加热段的组织与织构演变

利用扫描电镜、X射线衍射和电子背散射衍射技术研究了微碳DP钢在连续退火加热段的组织与织构演变。结果表明:热轧组织为铁素体加退化态珠光体,冷轧过程中铁素体被拉长并出现一定量的形变带;再结晶初期(720℃到750℃),多边形铁素体体积分数约30%,形变带易诱发{001}~{112}110取向晶粒优先形核与长大;再结晶后期(750℃到780℃),铁素体完全再结晶,硬质相逐渐溶解,111//ND纤维晶粒逐渐吞噬110//RD晶粒而长大。{001}110取向密度在再结晶初期和相变阶段剧烈增加,而相变对111//ND织构影响较小。     

67%变形量纯钨轧板在1250 ℃退火过程中的再结晶行为

目的 研究轧制压下量为67％的纯钨板在退火过程中的再结晶行为.方法 对67％变形量纯钨板在1250℃下进行等温退火实验,运用电子背散射衍射技术获得了变形态和退火态的显微组织与织构,量化了其晶粒尺寸、纵横比以及主要纤维织构的体积分数,分析了变形态组织中潜在晶核的信息.在此基础上,对再结晶前后的显微组织和织构进行了对比分析.结果 温轧后纯钨板的组织中包含了潜在的再结晶晶核,W67在1250℃下退火过程中以较快速度发生了不连续静态再结晶.结论 随着退火时间的增加,再结晶晶粒的尺寸逐渐增大,但其纵横比基本保持不变.在再结晶过程中,θ纤维织构和α纤维织构有所增加,而γ纤维织构明显减少.     

脉中电流对2091铝锂合金动态再结晶动力学的影响

研究了脉冲电流对2091铝锂合金超塑变形中动态再结晶及动力学的影响结果表明,脉冲电流加速动态再结晶,减小形核时的平均晶粒直径.脉冲电流能加快位错墙的形成并使其角度增大,使再结晶形核率提高.脉冲电流加快位错在晶界上的攀移及消失、减小形核界面两边的能量差,降低形核界面的迁移速率及再结晶形核的长大速率分析了脉冲电流作用下的动态再结晶动力学行为     

冷轧高纯钽板退火过程中微观组织及织构演变的梯度效应

本研究综合采用电子背散射衍射(EBSD)、X射线衍射(XRD)和显微硬度等技术,系统研究了87%周向轧制钽板在1 323 K下经5 min、10 min、30 min、60 min、90 min和120 min退火后沿厚度方向的显微组织演变规律。实验结果表明,中心区域的形变组织率先产生再结晶晶核且该区域的形核过程主要由大角度晶界形核机制主导,而近表面区域的形核则由亚晶形核机制发挥主要作用。其次,中心区域比近表面区域表现出更快的再结晶动力学,再结晶完成后,中心{111}〈uvw〉织构(〈111〉∥ND(板法向))强度高,而近表面{100}〈uvw〉织构(〈100〉∥ND)强度相对较高。变形钽板中心区域的{111}〈uvw〉织构强度高,储存能高且晶粒内部分裂严重,所以较早发生再结晶;而近表面区域{100}〈uvw〉织构强度高且晶粒内部分裂程度相对较小,储存能低,使得回复孕育期较长。由此导致再结晶组织和织构沿厚度方向上产生梯度效应。     

Gender differences in publication productivity in psychology in India

An analysis of gender differences in psychology in India provides quantitative and qualitative assessment of R&D output contributed by psychologists with the indication of the trend of growth, skewness, relatedness, co-authorship pattern of productivity.     

Metrology in Chemistry in Germany

The system for Metrology in Chemistry in Germany is described. At the national standards level, a network of high-level chemistry institutes coordinated by the national metrology institute, PTB, provides the primary references for chemical measurements. A dissemination mechanism employs chemical calibration laboratories accredited within the framework of the German Calibration Service (DKD). They act as “multipliers” between the national standards level and the user level by providing the user with calibration means which are traceable to the SI via national standards. Traceability structures in clinical chemistry, electrochemistry, elemental analysis and gas analysis are described     

Natural radioactivity in drinking water in private wells in Finland

Natural radioactivity in drinking water was determined in population-based random study of 472 private wells. The mean concentrations of (222)Rn, (226)Ra, (234)U, (238)U, (210)Pb and (210)Po in drilled wells were 460, 0.05, 0.35, 0.26, 0.04 and 0.05 Bq l(-1), and in wells dug in the soil were 50, 0.016, 0.02, 0.015, 0.013 and 0.007 Bq l(-1), respectively. Approximately 10% of the drilled wells exceeded a radon concentration of 1000 Bq l(-1) and 18% a uranium concentration of 15 microg l(-1). The mean annual effective dose from natural radionuclides for a drilled well user was 0.4 mSv and 0.05 mSv for a user of a well dug in the soil. The effective dose arising from (222)Rn was 75% of the total of all natural radionuclides for drilled well users. As regards long-lived radionuclides, (210)Po and (210)Pb caused the largest portion of the effective dose. The dose arising from (238)U, (234)U and (226)Ra was only 8% of the total of all natural radionuclides.     

Natural radioactivity in drinking water in private wells in Finland

Radiation Protection Dosimetry     

Optische in situ Schichtdickenmessung in Bedampfungsanlagen. Optical in situ film thickness monitoring in coating systems

Optical film thickness monitoring is more precise than crystal monitoring. The optical measurement makes use of the fact that the intensity of a monochromatic light beam which is reflected on a film will change periodically with increasing film thickness. The measurement is performed at an exchangeable test glass that is positioned beside the substrates and is therefore coated in the same way as the substrates. The accuracy of cut‐off is achieved by a “fit” of a theoretical curve shape to the measured values. Order filters are used to ensure that, at a certain wavelength, higher deflection orders do not influence the measurement when a monochromator grating is used.     

Differences in coagulation in clotting of vascular access in hemodialysis patients

Arteriovenous graft (AVG) thrombosis is a frequent cause of graft failure. We evaluated coagulation protein concentrations, platelet function, and viscoelasticity factors in 20 hemodialysis (HD) patients with AVGs. The goal was to determine whether significant differences in protein concentrations, platelet function, and viscoelasticity factors exist among dialysis patients requiring frequent AVG declot procedures vs. those who do not. Twenty HD patients were enrolled: 10 frequent clotters (>3 declots in the previous year) and 10 were nonclotters. Patients on antiplatelets or chronic anticoagulation were excluded. Laboratories were drawn pretreatment and heparinase was added to counteract any potential heparin effect. Coagulation protein concentrations including tissue factor (TF), thrombin/antithrombin III complex (TAT), and prothrombin fragment 1 + 2 (F₁₊₂) were assayed. The time to clot onset was measured by force onset time (FOT). Platelet contractile force (PCF) measured the force produced by platelets during clot retraction, whereas clot rigidity was measured as clot elastic modulus (CEM). FOT, CEM, and PCF were measured by Hemodyne. Both groups had upregulation of the TF pathway, as TF, TAT, and F₁₊₂ levels were similarly increased over baseline levels. Hemodialysis patients with frequent AVG clotting had higher levels of both PCF and CEM compared with nonclotters. Additionally, the frequent clotters had a lower FOT relative to nonclotters, although both were considered in the normal range. Our study suggests that HD patients with recurrent AVG thrombotic events form clots with higher tensile strength compared with HD patients without recurrent graft thrombosis.     

Spanish experience in education and training in radiation protection in medicine

In most of its publications, the International Commission on Radiological Protection has highlighted the importance of education and training in radiation protection (RP) for medical exposures. Spain, like other Member States of the European Union, has implemented the Directive and the Guidelines in the medical area. The purpose of this paper is to present the Spanish experience in RP education and training in medicine, the different objectives established according to professional levels, existing regulations and feedback obtained from various RP actions.